BioNTech SE BNTX is reportedly scheduled to appear in court on Monday to defend itself against a lawsuit filed by a German woman seeking damages for alleged side effects of BioNTech's COVID-19 vaccine.
The plaintiff claims to have experienced upper-body pain, swollen extremities, fatigue, and sleeping disorders since receiving the vaccine.
The initial hearing for this case will take place on Monday. The woman is suing BioNTech for at least €150,000 ($161,500) in damages for bodily harm and compensation for unspecified material damage.
The regional court in Hamburg is overseeing the proceedings, Reuters reported.
According to German pharmaceutical law, manufacturers of drugs or vaccines are only liable for damages caused by the side effects if "medical science" demonstrates that their products disproportionately harm individuals relative to their benefits or if the label information is incorrect.
BioNTech has developed the COVID vaccine in partnership with Pfizer Inc PFE, and it notes that over 1.5 billion people worldwide, including more than 64 million in Germany, have received the vaccine.
The EMA recently confirmed the benefits of all approved COVID-19 vaccines, including BioNTech's, stating that vaccines were estimated to have saved nearly 20 million lives globally in the first year of the pandemic alone.
Rogert & Ulbrich has filed approximately 250 cases for clients seeking damages for alleged side effects of COVID-19 vaccines. Another law firm, Caesar-Preller, has reported representing 100 cases.
Price Action: BNTX shares are down 0.56% at $108.64 during the premarket session on the last check Monday.
Photo via Wikimedia Commons
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
